pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
aglatimagene besadenovec
ProstAtak (aglatimagene besadenovec)
Prostate Cancer
$CADLCandel Therapeutics, Inc.
0 catalysts
Marketed
aldesleukin
Proleukin (aldesleukin)
Metastatic Renal Cell Carcinoma
$IOVAIOVANCE BIOTHERAPEUTICS, INC.
0 catalysts
Phase 3
aldoxorubicin
Metastatic Pancreatic Cancer
DNA topoisomerase 2-alpha
LadRx Corp
← prev
page 40 of 62
next →
131
Pain89
Neurology1
0 catalysts
Marketed
alectinib
Alecensa (alectinib)
Non-Small Cell Lung Cancer
F. Hoffmann-La Roche Ltd
0 catalysts
Marketed
alemtuzumab
Campath (alemtuzumab)
B-Cell Chronic Lymphocytic Leukemia
Genzyme Corp
0 catalysts
Phase 2
alintegimod
alintegimod [INN]
Colorectal Cancer
7 Hills Pharma LLC
0 catalysts
Phase 2
alisertib
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Aurora kinase A
$PBYIPUMA BIOTECHNOLOGY, INC.
0 catalysts
Marketed
allopurinol
Zyloprim (allopurinol)
Kidney Disease (Nephropathy)
Casper Pharma LLC
0 catalysts
Phase 2
alnodesertib
alnodesertib [INN]
Metastatic Colorectal Cancer
Artios Pharma Ltd
0 catalysts
Marketed
alpelisib
Piqray (alpelisib)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$NVSNOVARTIS AG
0 catalysts
Phase 2
alrizomadlin
alrizomadlin [INN]
Lung Adenocarcinoma
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
0 catalysts
Phase 2
amezalpat
amezalpat [INN]
Metastatic Hepatocellular Carcinoma (HCC)
$TPSTTempest Therapeutics, Inc.
0 catalysts
Marketed
aminolevulinic acid hydrochloride
Ameluz (aminolevulinic acid hydrochloride)
Basal Cell Carcinoma (Basal Cell Epithelioma)
$BFRIBiofrontera Inc.
0 catalysts
Phase 2
amsulostat hydrochloride
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Syntara Ltd
0 catalysts
Phase 2
amulirafusp alfa
amulirafusp alfa [INN]
Marginal Zone B-Cell Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
0 catalysts
Phase 3
anamorelin hydrochloride
Cancer Anorexia-Cachexia Syndrome
Growth hormone secretagogue receptor type 1
Helsinn Healthcare SA
0 catalysts
pre_registration
anitocabtagene autoleucel
Refractory Multiple Myeloma
$ACLXArcellx, Inc.
0 catalysts
Phase 2
anvatabart opadotin
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
TubulinReceptor tyrosine-protein kinase erbB-2
Ambrx Biopharma Inc
0 catalysts
Phase 2
anvumetostat
anvumetostat [INN]
Metastatic Biliary Tract Cancer
$AMGNAMGEN INC
0 catalysts
Phase 2
anzutresgene autoleucel
anzutresgene autoleucel [INN]
Endometrial Cancer
Immatics NV
0 catalysts
Preclinical
apomorphine palmitate
Apomorphine palmitate
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Leukos Biotech SL
0 catalysts
Phase 2
arcotatug tavatecan
arcotatug tavatecan [INN]
Pancreatic Ductal Adenocarcinoma
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 3
arlocabtagene autoleucel
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0 catalysts
Phase 2
ascrinvacumab
Metastatic Hepatocellular Carcinoma (HCC)
Activin receptor type-1-like
Kintor Pharmaceutical Ltd
0 catalysts
Phase 2
aspacytarabine hydrochloride
Astarabine (aspacytarabine hydrochloride)
Refractory Acute Myeloid Leukemia
Ayala Pharmaceuticals Inc.
0 catalysts
Phase 2
atebimetinib
atebimetinib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
$IMRXImmuneering Corp
0 catalysts
Phase 2
ateganosine
Non-Small Cell Lung Cancer
$MAIAMAIA Biotechnology, Inc.
0 catalysts
Phase 2
autogene cevumeran
Solid Tumor
Genentech Inc
0 catalysts
Marketed
avapritinib
Ayvakit (avapritinib)
Gastrointestinal Stromal Tumor (GIST)
Blueprint Medicines Corp
0 catalysts
Marketed
avutometinib potassium
Fallopian Tube Cancer
$VSTMVerastem, Inc.
0 catalysts